International Briefs: Australia’s IVD Framework; NICE Supports Two Devices
This article was originally published in The Gray Sheet
Abbott weighs in on proposed amendments to Australia’s in vitro diagnostics regulatory framework. NICE gives thumbs-up to intubation and amniotic fluid leak detection devices.
You may also be interested in...
Recent meeting of the International Medical Device Regulators Forum draws a big audience. Two devices receive draft support from the U.K.'s National Institute for Health and Clinical Excellence.
In this week's podcast edition of Five Must-Know Things: GSK’s R&D head departs; Bayer’s pharma R&D chief prioritizes assets; new US launches in atopic dermatitis; is Abivax an M&A target; and China’s gene therapy developers rush to the clinic.
Novo Nordisk's oral semaglutide debuts in India at a monthly cost of about $135 and promises to transform diabetes management in the country. Will it impact the SGLT-2 inhibitor class and potentially cannibalize injectable GLP-1 receptor agonists?